Angion Biomedica (ANGN) Balance Sheet

Click line-items for a historical chart and %

ASSETS
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowance for doubtful accounts of $46 and $100, respectively	6.5M
Inventories, net of obsolescence reserve of $572 and $599, respectively	7.02M
Prepaid expenses and other current assets	603K
Total Current Assets	19.89M
Noncurrent investments
Property and equipment, net of accumulated depreciation of $3,706 and $3,649, respectively	2.75M
Intangible assets, net	4.44M
Total Assets	33.39M
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	2.35M
Employee compensation	1.54M
Deferred income	3.77M
Warranty reserve
Other current liabilities and accrued expenses	950K
Total Current Liabilities	8.61M
Long-term Liabilities:
Long-term deferred income and other	3.96M
Total Liabilities	12.57M
Commitments and Contingencies	0
Shareholders' Equity:
Common Stock, $0.10 par value, authorized 25,000,000 shares, 3,897,243 and 3,862,113 shares issued and 3,768,417 and 3,747,454 shares outstanding at 2011 and 2010, respectively	433K
Additional paid-in capital	24.72M
Accumulated deficit	-4.05M
Accumulated other comprehensive income	-272K
Total Shareholders' Equity	20.82M
Total Liabilities and Shareholders' Equity	33.39M

Entities mentioned with ANGN